Jaguar Health (JAGX) FCF Margin (2015 - 2026)

Jaguar Health's (JAGX) quarterly FCF Margin came in at 43.74% in Q1 2026, up 37409.0% year-on-year from N/an in Q1 2025, and up 133.21% on a QoQ basis from 131.72% in Q4 2025.

Jaguar Health (JAGX) FCF Margin (2015 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 12 years of FCF Margin data on file, last reported at 43.74% in Q1 2026.

  • On a quarterly basis, FCF Margin rose 37409.0% year-over-year to 43.74% in Q1 2026; TTM through Mar 2026 was 21.77%, a 24140.0% increase from a year earlier, with the FY2025 full-year figure at 195.58%, up 5594.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 43.74%, up from 131.72% in the prior quarter.
  • Over the last five years, FCF Margin for JAGX reached as high as 43.74% in Q1 2026 and fell as low as 38500.0% in Q1 2022.
  • Historically, FCF Margin has averaged 4705.21% across 5 years, with a median of 278.97% in 2022.
  • Across the five-year window, FCF Margin plunged 3794619 bps in 2022 and jumped 2187152 bps in 2024, its largest moves.
  • Year by year, FCF Margin stood at 15953.12% in 2022, then jumped by 98 bps to 323.83% in 2023, then jumped by 34 bps to 214.05% in 2024, then jumped by 38 bps to 131.72% in 2025, then surged by 133 bps to 43.74% in 2026.
  • Per Business Quant data, the three most recent FCF Margin figures were 43.74% in Q1 2026, 131.72% in Q4 2025, and 157.28% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Nanobiotix 1,782.24 Bn 1,782.18 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
3 BeOne Medicines 473.46 Bn 468.66 Bn 1.35 Bn 10.45%
4 Vertex Pharmaceuticals 123.84 Bn 116.59 Bn 2.59 Bn 43.35%
5 Regeneron Pharmaceuticals 71.69 Bn 62.94 Bn 3.31 Bn 23.53%
6 Belite Bio 62.15 Bn 62.15 Bn - -
7 Argenx Se 54.74 Bn 49.55 Bn 1.41 Bn -
8 Alnylam Pharmaceuticals 38.08 Bn 35.07 Bn 959.66 Mn 4.17%
9 Revolution Medicines 36.07 Bn 36.07 Bn - -
10 Jaguar Health 520,945.88 -9.54 Mn 19.11 Mn 43.74%

Historic Data

Download Data
DateValue
Mar 31, 2026 43.74%
Dec 31, 2025 -131.72%
Sep 30, 2025 -157.28%
Jun 30, 2025 -207.96%
Mar 31, 2025 -330.35%
Dec 31, 2024 -214.05%
Sep 30, 2024 -214.16%
Jun 30, 2024 -327.86%
Mar 31, 2024 -268.48%
Dec 31, 2023 -323.83%
Sep 30, 2023 -241.52%
Jun 30, 2023 -344.65%
Mar 31, 2023 -22,140.00%
Dec 31, 2022 -15,953.13%
Sep 30, 2022 -278.97%
Jun 30, 2022 -398.36%
Mar 31, 2022 -38,500.00%
Dec 31, 2021 -431.06%
Sep 30, 2021 -1,533.66%
Jun 30, 2021 -2,608.97%